tirzepatide clinical trials after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide for Weight Loss |

Why Weight Regain Happens After Stopping GLP-1 Drugs Once medication stops: appetite returns cravings rebound GLP-1 levels normalize dysbiosis remains SCFAs remain low circadian rhythm remains disrupted Metabolic relapse happens because the ecosystem was never rebuilt

GPS has the ability to control the expression of genes that are involved in lipid metabolism, including peroxisome proliferator-activated receptor- (PPAR-) and sterol regulatory element-binding protein-1c (SREBP-1c)

Despite tirzepatide producing substantially greater average weight loss, it does not carry a meaningfully higher gastrointestinal burden in these pooled analyses

E.YoonY

Anti-NGF antibody injections showed great effectiveness in reducing pain but also accelerated the development of osteoarthritis, if recipients were already taking NSAIDs (241243)

Serious Health Complications Linked to Wegovy Some Wegovy patients in Dallas-Fort Worth have reported having severe side effects and medical problems